Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$165.67 - $199.94 $674,276 - $813,755
4,070 Added 4.44%
95,661 $16.2 Million
Q4 2023

Jan 23, 2024

BUY
$151.44 - $200.09 $860,179 - $1.14 Million
5,680 Added 6.61%
91,591 $18.1 Million
Q3 2023

Nov 21, 2023

BUY
$167.14 - $192.77 $4.56 Million - $5.25 Million
27,253 Added 46.46%
85,911 $14.9 Million
Q2 2023

Jul 28, 2023

BUY
$160.94 - $186.23 $6.68 Million - $7.73 Million
41,528 Added 242.43%
58,658 $10.1 Million
Q1 2023

May 08, 2023

BUY
$145.48 - $175.02 $662,661 - $797,216
4,555 Added 36.22%
17,130 $2.85 Million
Q4 2022

Feb 07, 2023

SELL
$131.14 - $157.47 $6.29 Million - $7.55 Million
-47,948 Reduced 79.22%
12,575 $1.84 Million
Q3 2022

Nov 08, 2022

SELL
$148.29 - $182.55 $1.42 Million - $1.75 Million
-9,600 Reduced 13.69%
60,523 $8.98 Million
Q2 2022

Jul 27, 2022

SELL
$155.97 - $200.09 $5.94 Million - $7.62 Million
-38,063 Reduced 35.18%
70,123 $12.1 Million
Q1 2022

Apr 28, 2022

SELL
$181.39 - $234.03 $2.25 Million - $2.9 Million
-12,402 Reduced 10.28%
108,186 $20.4 Million
Q4 2021

Jan 25, 2022

SELL
$193.69 - $247.03 $341,475 - $435,513
-1,763 Reduced 1.44%
120,588 $29.4 Million
Q3 2021

Dec 01, 2021

SELL
$189.29 - $209.69 $551,401 - $610,826
-2,913 Reduced 2.33%
122,351 $23.8 Million
Q2 2021

Jul 23, 2021

SELL
$155.9 - $187.99 $64,542 - $77,827
-414 Reduced 0.33%
125,264 $23.3 Million
Q1 2021

Apr 28, 2021

SELL
$144.0 - $169.39 $551,952 - $649,271
-3,833 Reduced 2.96%
125,678 $19.8 Million
Q4 2020

Feb 03, 2021

BUY
$157.07 - $174.35 $375,711 - $417,045
2,392 Added 1.88%
129,511 $21.4 Million
Q3 2020

Oct 27, 2020

SELL
$137.1 - $165.37 $246,505 - $297,335
-1,798 Reduced 1.39%
127,119 $21 Million
Q2 2020

Aug 06, 2020

BUY
$111.92 - $142.53 $471,518 - $600,478
4,213 Added 3.38%
128,917 $17.7 Million
Q1 2020

Jun 09, 2020

SELL
$92.66 - $144.94 $879,158 - $1.38 Million
-9,488 Reduced 7.07%
124,704 $14.7 Million
Q4 2019

Jan 24, 2020

SELL
$116.25 - $133.25 $5.63 Million - $6.46 Million
-48,464 Reduced 26.53%
134,192 $17.8 Million
Q3 2019

Oct 31, 2019

BUY
$112.57 - $128.43 $475,383 - $542,359
4,223 Added 2.37%
182,656 $22.8 Million
Q2 2019

Jul 25, 2019

SELL
$97.98 - $114.28 $249,555 - $291,071
-2,547 Reduced 1.41%
178,433 $20.3 Million
Q1 2019

Apr 25, 2019

BUY
$81.56 - $100.67 $13,865 - $17,113
170 Added 0.09%
180,980 $18.2 Million
Q4 2018

Jan 28, 2019

SELL
$79.28 - $95.27 $580,012 - $696,995
-7,316 Reduced 3.89%
180,810 $15.5 Million
Q3 2018

Oct 29, 2018

SELL
$83.5 - $93.23 $979,872 - $1.09 Million
-11,735 Reduced 5.87%
188,126 $17.2 Million
Q2 2018

Aug 01, 2018

SELL
$79.9 - $89.2 $1.49 Million - $1.66 Million
-18,589 Reduced 8.51%
199,861 $17 Million
Q1 2018

May 01, 2018

SELL
$71.51 - $84.69 $723,681 - $857,062
-10,120 Reduced 4.43%
218,450 $18.2 Million
Q4 2017

Jan 30, 2018

BUY
$63.24 - $72.8 $176,439 - $203,112
2,790 Added 1.24%
228,570 $16.5 Million
Q3 2017

Oct 25, 2017

BUY
$59.73 - $65.4 $13.5 Million - $14.8 Million
225,780
225,780 $14.4 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $90.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Braun Stacey Associates Inc Portfolio

Follow Braun Stacey Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braun Stacey Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Braun Stacey Associates Inc with notifications on news.